Sam Lee
Chief Scientific Officer, Co-Founder & PresidentDr. Sam Lee, Ph.D., is Chief Scientific Officer of Cocrystal Pharma, Inc. from June 03, 2026. Dr. Lee was Co-CEO of Cocrystal Pharma, Inc. from May 2023 to June 03, 2026. Dr. Lee Co-founded Cocrystal Pharma, Inc. in 2008 and serves as its President since January 2, 2014 and serves as its Interim Co-Chief Executive Officer since May 2023 and had been its Interim Co-Chief Executive Officer since May 26, 2021 until May 2023. Dr. Lee served as a Scientist at Icos Corporation for few years, where he led drug discovery teams using a structural biology approach. He is a co-founder of Cocrystal Discovery and has been President and a director of Cocrystal Discovery since 2007. He served as a Director of Cocrystal Pharma, Inc. since January 2, 2014 until November 22, 2014. His postdoctoral work at Stanford University centered on the replication enzymes of herpes viruses. Dr. Lee founded and was Chief Executive Officer of Viral Assays in Cupertino, CA. He received his Ph.D. in Biological Sciences from the University of Notre Dame and completed postdoctoral training in viral replication biochemistry with Dr. I. R. Lehman at Stanford University.
Positions
- Company NameCocrystal Pharma, Inc.Stock CodeCOCPPositionChief Scientific Officer, Co-Founder & PresidentColleagues
- RDRoger D. KornbergCo-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board
- JJJames J. MartinCFO & Corporate Secretary
- JRJames R. SapirsteinChief Executive Officer
- SDSteven D. RubinIndependent Vice Chairman
- RCRichard C. PfennigerIndependent Director
- PFPhillip FrostIndependent Director
- MLMichael LevittMember of Scientific Advisory Board
